Ruta chalepensis (Fringed Rue)

Ruta chalepensis contains bioactive compounds chalepin and pseudane IX that demonstrate antiparasitic activity in laboratory studies. The plant also produces graveoline, which shows antifungal properties by inhibiting key enzymes in Candida albicans.

Origin & History

Ruta chalepensis (fringed rue) is a perennial herbaceous plant native to the Mediterranean region, belonging to the Rutaceae family. The plant's aerial parts, including leaves and flowers, are processed through solvent extraction (dichloromethane, methanol, chloroform) or steam distillation to obtain bioactive compounds and essential oils.

Historical & Cultural Context

Ruta chalepensis has been used for centuries in Mediterranean and Middle Eastern traditional medicine systems as a folk remedy for gastrointestinal issues, infections, and as an anthelmintic. Historical phytochemical records date back over 60 years, with traditional preparations typically involving infusions or extracts of aerial parts.

Health Benefits

• May possess antiparasitic properties - in vitro studies show chalepin and pseudane IX demonstrate activity against parasites (IC50 = 1.6 µg/mL and 1.4 µg/mL respectively) - preliminary evidence only
• Potential antifungal activity - graveoline inhibits isocitrate lyase 1 in Candida albicans in laboratory studies - no human trials
• Possible blood sugar support - compounds rutamarin and chalepin act as PPARγ:RXRα agonists and enhance GLUT4 translocation in cell studies - no clinical data
• Traditional anthelmintic use - essential oil components 2-undecanone and 2-nonanone show activity against gastrointestinal nematodes in vitro - lacks human studies
• Potential anticancer properties - chalepin and rutamarin induce apoptosis through mitochondrial disruption and ROS production in cancer cell lines - no human trials conducted

How It Works

Chalepin and pseudane IX from Ruta chalepensis demonstrate antiparasitic activity with IC50 values of 1.6 µg/mL and 1.4 µg/mL respectively in vitro. The alkaloid graveoline exerts antifungal effects by specifically inhibiting isocitrate lyase 1, a key enzyme in Candida albicans metabolism.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Ruta chalepensis. All available evidence is limited to in vitro studies using cell lines and isolated compounds, with no PMIDs available for human trials.

Clinical Summary

Current evidence for Ruta chalepensis is limited to in vitro laboratory studies examining isolated compounds. The antiparasitic studies tested chalepin and pseudane IX against parasites with measurable inhibitory concentrations, while antifungal research focused on graveoline's enzyme inhibition. No human clinical trials have been conducted to validate these preliminary findings. The evidence strength remains preliminary and requires further research in animal models and human subjects.

Nutritional Profile

Ruta chalepensis is a herb used in small culinary and medicinal quantities, limiting significant macronutrient contribution. Macronutrient data specific to this species is sparse; as with related Ruta graveolens, dried aerial parts contain modest protein (~8-12% dry weight), minimal fats, and some dietary fiber (~15-20% dry weight), though these are not nutritionally significant at typical use doses. Key bioactive compounds are the primary nutritional-pharmacological interest: (1) Furanocoumarins - bergapten, xanthotoxin, and isopimpinellin present at approximately 0.1-0.5% dry weight in leaves; (2) Alkaloids - graveoline, graveolinine, and arborinine identified in leaf and stem tissue, with graveoline noted at trace-to-low concentrations (~0.05-0.2% dry weight); (3) Coumarins - rutamarin and chalepin reported at approximately 0.1-0.3% dry weight, with chalepin showing higher concentration in root bark than aerial parts; (4) Flavonoids - rutin (quercetin-3-rutinoside) is notably present at approximately 0.5-1.5% dry weight in leaves, contributing antioxidant activity; bioavailability of rutin is moderate (~20-30% absorption) due to glycoside form requiring intestinal hydrolysis; (5) Essential oils - limonene, 2-undecanone, and 2-nonanone comprise the primary volatile fraction (~0.3-0.7% fresh weight); (6) Pseudane IX alkaloid present in aerial parts at trace concentrations. Vitamin and mineral content is not well-characterized for this specific species; assumed broadly similar to other small Mediterranean herbs with negligible contributions to RDI at typical doses. Bioavailability of furanocoumarin compounds is generally high via passive diffusion but subject to CYP3A4 inhibition interactions.

Preparation & Dosage

No clinically studied dosage ranges are available due to absence of human trials. In vitro studies used concentrations like IC50 = 1.6 µg/mL for extracts, but no standardized forms (extract percentages, powder dosages) have been established for human use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, dandelion root, oregano oil, berberine, gymnema sylvestre

Safety & Interactions

Ruta chalepensis safety profile in humans is not well-established due to lack of clinical studies. Traditional rue species contain potentially toxic compounds and may cause photosensitivity reactions when combined with sun exposure. Pregnant women should avoid this herb as rue species have historically been associated with uterine stimulation. No specific drug interactions have been documented, but caution is advised given the limited safety data.